What is Shandong Boan Biotechnology Co Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shandong Boan Biotechnology Co's Average Total Inventories for the quarter that ended in Dec. 2023 was HK$178.1 Mil. Shandong Boan Biotechnology Co's Revenue for the
six
months ended in Dec. 2023 was HK$390.4 Mil.
Shandong Boan Biotechnology Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.46.
Shandong Boan Biotechnology Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023
declined
from Jun. 2023 (0.59) to Jun. 2023 (0.46)
A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Shandong Boan Biotechnology Co's Days Inventory for the
six
months ended in Dec. 2023 was 279.92.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Shandong Boan Biotechnology Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.65.
Shandong Boan Biotechnology Co Inventory-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shandong Boan Biotechnology Co Inventory-to-Revenue Chart
Competitive Comparison of Shandong Boan Biotechnology Co's Inventory-to-Revenue
For the Biotechnology subindustry, Shandong Boan Biotechnology Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Boan Biotechnology Co's Inventory-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shandong Boan Biotechnology Co's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Shandong Boan Biotechnology Co's Inventory-to-Revenue falls into.
Shandong Boan Biotechnology Co Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Boan Biotechnology Co (HKSE:06955) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Shandong Boan Biotechnology Co's Days Inventory for the
six
months ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Boan Biotechnology Co Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Shandong Boan Biotechnology Co (HKSE:06955) Business Description
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06955 has been successfully added to your